Literature DB >> 25265459

Serum immunoglobulin free light chains and post-transplant lymphoproliferative disorder among allogeneic hematopoietic stem cell transplant recipients.

E A Engels1, O Landgren2, R Costello3, D Burton3, S Mailankody3, J Storek4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25265459      PMCID： PMC6298742          DOI： 10.1038/bmt.2014.213

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.

Authors:  E A Engels; J Preiksaitis; A Zingone; O Landgren
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

2.  High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts.

Authors:  M Hoegh-Petersen; D Goodyear; M N Geddes; S Liu; A Ugarte-Torres; Y Liu; J T Walker; K Fonseca; A Daly; P Duggan; D Stewart; J A Russell; J Storek
Journal:  Bone Marrow Transplant       Date:  2010-11-08       Impact factor: 5.483

3.  Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.

Authors:  J-E Gottenberg; F Aucouturier; J Goetz; C Sordet; I Jahn; M Busson; J-M Cayuela; J Sibilia; X Mariette
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

Review 4.  Immune reconstitution after hematopoietic cell transplantation.

Authors:  Mark Bosch; Faisal M Khan; Jan Storek
Journal:  Curr Opin Hematol       Date:  2012-07       Impact factor: 3.284

5.  Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients.

Authors:  Eric A Engels; Barbara Savoldo; Ruth M Pfeiffer; Rene Costello; Adriana Zingone; Helen E Heslop; Ola Landgren
Journal:  Transplantation       Date:  2013-02-15       Impact factor: 4.939

6.  Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival.

Authors:  Z Y Lim; W Ingram; R Brand; M Akthari; D Milojkovic; A Y L Ho; S Devereux; A Pagliuca; R F Duarte; G J Mufti
Journal:  Bone Marrow Transplant       Date:  2007-08-20       Impact factor: 5.483

7.  Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.

Authors:  B Terrier; D Sène; D Saadoun; P Ghillani-Dalbin; V Thibault; A Delluc; J-C Piette; P Cacoub
Journal:  Ann Rheum Dis       Date:  2008-03-28       Impact factor: 19.103

8.  Paraproteinemia after hematopoietic stem cell transplantation.

Authors:  Takahiro Nagashima; Kazuo Muroi; Chizuru Kawano-Yamamoto; Norio Komatsu; Keiya Ozawa
Journal:  Leuk Lymphoma       Date:  2004-01

9.  Circulating serum free light chains as predictive markers of AIDS-related lymphoma.

Authors:  Ola Landgren; James J Goedert; Charles S Rabkin; Wyndham H Wilson; Kieron Dunleavy; Robert A Kyle; Jerry A Katzmann; S Vincent Rajkumar; Eric A Engels
Journal:  J Clin Oncol       Date:  2010-01-04       Impact factor: 44.544
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.